datma Joins GOAL Consortium as a Key Industry Supporter
datma, a leading provider of federated Real-World Data platform and related analytical tools, today announced its role as a GOAL Industry Member Supporter for the Genomics...
Tag : cancer biomarkers
Precision Medicine Group Announces Key Leadership Appointments
Karl Deonanan appointed Chief Financial Officer Matt DeZee named to newly established role, Chief Transformation and Strategy Officer Precision Medicine Group (Precision), a leading next-generation provider of...
Canary Speech Launches Canary Ambient™
Canary Ambient™ enables actionable insights into patient-clinician dialogues, tracking speech patterns, and delivering real-time evaluations of cognitive and behavioral health conditions Canary Speech, a leader...
Lunaphore announced partnership with Discovery Life Sciences
Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore, is partnering with Discovery Life Sciences (Discovery) to add Lunaphore COMET™, a best-in-class spatial biology platform,...
Almaden Genomics Launches Data Management, Informatics Services business
Almaden Genomics has launched a new Data Management and Informatics Services business to support its bioinformatics and computational biology solutions. This expansion underscores Almaden’s commitment...
Circular Genomics Announced Launch of MindLight™
MindLight™ identifies the presence of a circular RNA biomarker that can predict the likelihood of response to SSRI medication for patients diagnosed with depression Circular...
Canary Speech Receives Patent for Paired Neural Networks Technology
New patent is a major advancement in the capabilities of speech analysis and has the potential to revolutionize various industries including healthcare and customer service...
Imagene Partners with Oracle to Launch CanvOI on OCI
CanvOI Oncology Intelligence (OI) foundation model is designed to decode cancer from biopsy images and drive cancer research forward Oracle and Imagene, a pioneer in AI-based precision...
Lunit Joins Roche’s Digital Pathology Open Environment
Lunit’s AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche’s navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing Lunit (KRX:328130.KQ), a...
Dxcover names first US Scientific Advisory Board Member
Luke Pike MD, DPhil, Radiation Oncologist, joins Dxcover Scientific Advisory Board to advise the company on brain cancer diagnostic early detection clinical applications Dxcover Limited, a...